MLchartDataset catalogue

PNU-93914

Term · Oncology and biomedicine · MLC-T-ONC-006776

A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. PNU-93914 blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called LEP-ETU, liposomal paclitaxel, LipoTaxen, and paclitaxel liposome.

Table 1. Record
IdentifierMLC-T-ONC-006776
FieldOncology and biomedicine
Expansionsliposomal paclitaxel; LipoTaxen; paclitaxel liposome
SynonymsLEP-ETU
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-006776",
  "term": "PNU-93914",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. PNU-93914 blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called LEP-ETU, liposomal paclitaxel, LipoTaxen, and paclitaxel liposome.",
  "expansions": [
    "liposomal paclitaxel",
    "LipoTaxen",
    "paclitaxel liposome"
  ],
  "synonyms": [
    "LEP-ETU"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/pnu-93914/"
}

Record 13,397 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.